Literature DB >> 30594618

Alkali-soluble polysaccharides from mushroom fruiting bodies improve insulin resistance.

Siwen Yang1, Jingmin Yan1, Lulu Yang1, Yuhan Meng1, Na Wang1, Congcong He2, Yuying Fan3, Yifa Zhou4.   

Abstract

Insulin resistance is the main cause of type 2 diabetes. Polysaccharide is one of the main active components in mushrooms. Some mushroom polysaccharides have been reported to have beneficial effects against type 2 diabetes. However, the structural features and mechanisms of polysaccharides with hypoglycemic activity have not been elucidated. In this paper, six alkali-soluble total polysaccharides, six neutral polysaccharides and six acidic polysaccharides were extracted and purified from mushrooms fruiting bodies of different species. The effects of these polysaccharides on improving insulin resistance were compared using high fatty acids and glucose-induced hepatocytes. Among them, the neutral polysaccharide AAMP-N of Armillaria mellea fruiting body showed the most significant activity, indicating that mannogalactoglucan is the main active domain. AAMP-N enhanced insulin sensitivity in vitro. Also AAMP-N lowered blood glucose, and modulated lipid metabolism in db/db mice. In addition, AAMP-N protected damaged pancreatic islets in mice. Our results demonstrated the role of natural polysaccharides from mushrooms in the improvement of insulin sensitivity and lipid metabolism, and provided basis for the development of mushroom polysaccharides as hypoglycemic healthy food.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Insulin resistance; Mushrooms polysaccharides; Type 2 diabetes

Mesh:

Substances:

Year:  2018        PMID: 30594618     DOI: 10.1016/j.ijbiomac.2018.12.251

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  8 in total

1.  Neutral Polysaccharides From Hohenbuehelia serotina With Hypoglycemic Effects in a Type 2 Diabetic Mouse Model.

Authors:  Qinghong Liu; Jing Wu; Peng Wang; Yuxiao Lu; Xinhe Ban
Journal:  Front Pharmacol       Date:  2022-05-05       Impact factor: 5.988

2.  Anti-Diabetic Nephropathy Activities of Polysaccharides Obtained from Termitornyces albuminosus via Regulation of NF-κB Signaling in db/db Mice.

Authors:  Chang Yang; Qi Feng; Huan Liao; Xinlei Yu; Yang Liu; Di Wang
Journal:  Int J Mol Sci       Date:  2019-10-21       Impact factor: 5.923

Review 3.  Medicinal Components in Edible Mushrooms on Diabetes Mellitus Treatment.

Authors:  Arpita Das; Chiao-Ming Chen; Shu-Chi Mu; Shu-Hui Yang; Yu-Ming Ju; Sing-Chung Li
Journal:  Pharmaceutics       Date:  2022-02-17       Impact factor: 6.321

4.  Ginsenoside Compound K Protects against Obesity through Pharmacological Targeting of Glucocorticoid Receptor to Activate Lipophagy and Lipid Metabolism.

Authors:  Siwen Yang; Ting Liu; Chenxing Hu; Weili Li; Yuhan Meng; Haiyang Li; Chengcheng Song; Congcong He; Yifa Zhou; Yuying Fan
Journal:  Pharmaceutics       Date:  2022-06-02       Impact factor: 6.525

5.  A Novel Polysaccharide From Heimioporus retisporus Displays Hypoglycemic Activity in a Diabetic Mouse Model.

Authors:  Xiaobin Feng; Peng Wang; Yuxiao Lu; Zejun Zhang; Chunxin Yao; Guoting Tian; Qinghong Liu
Journal:  Front Nutr       Date:  2022-07-11

Review 6.  Compounds purified from edible fungi fight against chronic inflammation through oxidative stress regulation.

Authors:  Yidan Xia; Dongxu Wang; Jiaqi Li; Minqi Chen; Duo Wang; Ziping Jiang; Bin Liu
Journal:  Front Pharmacol       Date:  2022-09-09       Impact factor: 5.988

Review 7.  Occurrence and possible roles of polysaccharides in fungi and their influence on the development of new technologies.

Authors:  Jhonatas Rodrigues Barbosa; Raul Nunes de Carvalho Junior
Journal:  Carbohydr Polym       Date:  2020-06-13       Impact factor: 9.381

8.  Herbal formula LLKL ameliorates hyperglycaemia, modulates the gut microbiota and regulates the gut-liver axis in Zucker diabetic fatty rats.

Authors:  Mei Li; Lei Ding; Yu-Li Hu; Ling-Ling Qin; You Wu; Wei Liu; Li-Li Wu; Tong-Hua Liu
Journal:  J Cell Mol Med       Date:  2020-11-20       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.